ALEXANDRIA, Va., June 6 -- United States Patent no. 12,280,159, issued on April 22, was assigned to The Regents of The University of Michigan (Ann Arbor, Mich.).

"Therapeutic protein-based nanoparticles for treating cancer" was invented by Joerg Lahann (Ann Arbor, Mich.), Nahal Habibi (Ann Arbor, Mich.), Jason V. Gregory (Ann Abor, Mich.), Maria Castro (Ann Arbor, Mich.), Pedro Lowenstein (Ann Arbor, Mich.), Ava Mauser (Corrales, N.M.), Padma Kadiyala (Ann Arbor, Mich.), Daniel F. Quevedo (Lexington, Va.) and Felipe Nunez (Ann Arbor, Mich.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Protein-based nanoparticles for treating cancer, such as those characterized by intracranial tumors, and methods of forming ...